PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-67.89%
Negative revenue growth while FSLR stands at 85.62%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-214.64%
Negative gross profit growth while FSLR is at 32.39%. Joel Greenblatt would examine cost competitiveness or demand decline.
25.24%
EBIT growth below 50% of FSLR's 98.96%. Michael Burry would suspect deeper competitive or cost structure issues.
51.95%
Operating income growth at 50-75% of FSLR's 98.96%. Martin Whitman would doubt the firm’s ability to compete efficiently.
51.12%
Net income growth at 50-75% of FSLR's 101.27%. Martin Whitman would question fundamental disadvantages in expenses or demand.
51.26%
EPS growth at 50-75% of FSLR's 101.30%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
51.26%
Diluted EPS growth at 50-75% of FSLR's 101.30%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
0.33%
Share count expansion well above FSLR's 0.25%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.33%
Diluted share count expanding well above FSLR's 0.42%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-126.11%
Negative OCF growth while FSLR is at 60.46%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-145.35%
Negative FCF growth while FSLR is at 49.82%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
22.72%
10Y revenue/share CAGR under 50% of FSLR's 825.71%. Michael Burry would suspect a lasting competitive disadvantage.
-46.40%
Negative 5Y CAGR while FSLR stands at 49.09%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-58.19%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-589.71%
Negative 10Y OCF/share CAGR while FSLR stands at 780.35%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
25.26%
Below 50% of FSLR's 2639.60%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-321.17%
Negative 3Y OCF/share CAGR while FSLR stands at 248.27%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-5856.79%
Negative 10Y net income/share CAGR while FSLR is at 26.18%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-45.21%
Negative 5Y net income/share CAGR while FSLR is 101.69%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-281.88%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-30.93%
Negative equity/share CAGR over 10 years while FSLR stands at 850.53%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-46.59%
Negative 5Y equity/share growth while FSLR is at 35.37%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-36.42%
Negative 3Y equity/share growth while FSLR is at 7.94%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y dividend/share CAGR while FSLR stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
No Data
No Data available this quarter, please select a different quarter.
-20.67%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
6.59%
Inventory growth well above FSLR's 9.36%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-5.27%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-13.05%
We have a declining book value while FSLR shows 0.04%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
21.24%
Debt shrinking faster vs. FSLR's 47.23%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
-14.02%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
1.33%
We expand SG&A while FSLR cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.